Current role for cytoreduction and HIPEC for gastric cancer with peritoneal disease

Gastric cancer (GC) is an aggressive malignancy with a high burden of peritoneal disease. Evidence regarding the use of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) to improve outcomes has been growing. However, given multiple limitations, there remains a lack of...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Hamza, Johnston, Fabian M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322542/
https://www.ncbi.nlm.nih.gov/pubmed/35481913
http://dx.doi.org/10.1002/jso.26894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322542/
https://www.ncbi.nlm.nih.gov/pubmed/35481913
http://dx.doi.org/10.1002/jso.26894

Ejemplares similares